Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease

Identifying which neuropsychological measures detect early cognitive changes associated with Alzheimer disease (AD) brain pathology would be helpful clinically for the diagnosis of early AD and for the design of clinical trials. We evaluated which neuropsychological measures in our cognitive battery...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurobiol Aging
Autors principals: Schindler, Suzanne E., Jasielec, Mateusz S., Weng, Hua, Hassenstab, Jason J., Grober, Ellen, McCue, Lena M., Morris, John C., Holtzman, David M., Xiong, Chengjie, Fagan, Anne M.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5505233/
https://ncbi.nlm.nih.gov/pubmed/28482211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neurobiolaging.2017.04.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars